milvexian
bms
['milvexian']
a phase 2 dose-finding trial presented at #esccongress suggests the use of milvexian could reduce the risk of ischemic stroke by up to 30% without a major increase in the risk of bleeding events in certain doses. #stroke
Practical Cardiology provides timely reporting and commentary on the science and clinical practice of cardiovascular medicine.